The University of Tennessee Health Science Center
05/18/2026 | News release | Distributed by Public on 05/18/2026 10:28
UT Health Sciences News: Innovation Developed by UT Health Sciences Research Program Passes Landmark Trial for Cardiac Amyloidosis
A new diagnostic tool developed at the University of Tennessee Health Sciences may soon make it significantly easier for physicians to detect cardiac amyloidosis, a progressive and frequently underdiagnosed disease caused by abnormal protein deposits in the heart.
The tool is a novel imaging technology, a radioactive molecule that, when injected into a patient and scanned, lights up amyloid deposits in the heart, making a disease that was once nearly invisible on imaging clearly visible for the first time.
Read more on the UT Health Sciences News website.
Share this:
Related
The University of Tennessee Health Science Center published this content on May 18, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 18, 2026 at 16:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]